Baxter International (BAX) EBIT Growth (1y) (2010 - 2026)
Baxter International (BAX) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 30.74% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -10.28% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -95.55% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -1.28% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -38.47% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.53% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -15.42% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -116.77% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.61% |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -5.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.61% |
| Mar 31, 2026 | 13.79% |
| Mar 31, 2025 | -68.98% |
| Dec 31, 2024 | 48.45% |
| Sep 30, 2024 | 2,125.49% |
| Jun 30, 2024 | 6,164.71% |
| Mar 31, 2024 | 44.96% |
| Dec 31, 2023 | 307.05% |
| Sep 30, 2023 | 98.23% |
| Jun 30, 2023 | -106.44% |
| Mar 31, 2023 | -20.86% |
| Dec 31, 2022 | -1,456.52% |
| Sep 30, 2022 | -661.40% |
| Jun 30, 2022 | -37.74% |
| Mar 31, 2022 | -58.21% |
| Dec 31, 2021 | -94.33% |
| Sep 30, 2021 | 9.15% |
| Jun 30, 2021 | 28.10% |
| Mar 31, 2021 | -4.65% |
| Dec 31, 2020 | -24.25% |